BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31011396)

  • 1. Interstitial pneumonia in a glassblower: think to chronic beryllium disease!
    Jamoussi A; Merhabene T; Mlika M; Neji H; El Mezni F; Khelil JB; Besbes M
    Pan Afr Med J; 2018; 31():95. PubMed ID: 31011396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sarcoidosis and chronic beryllium disease: similarities and differences.
    Mayer AS; Hamzeh N; Maier LA
    Semin Respir Crit Care Med; 2014 Jun; 35(3):316-29. PubMed ID: 25007084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chest wall shrapnel-induced beryllium-sensitization and associated pulmonary disease.
    Fireman E; Shai AB; Lerman Y; Topilsky M; Blanc PD; Maier L; Li L; Chandra S; Abraham JM; Fomin I; Aviram G; Abraham JL
    Sarcoidosis Vasc Diffuse Lung Dis; 2012 Oct; 29(2):147-50. PubMed ID: 23461078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic Beryllium Disease: Update on a Moving Target.
    MacMurdo MG; Mroz MM; Culver DA; Dweik RA; Maier LA
    Chest; 2020 Dec; 158(6):2458-2466. PubMed ID: 32768458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of the blood beryllium lymphocyte proliferation test.
    Newman LS
    Environ Health Perspect; 1996 Oct; 104 Suppl 5(Suppl 5):953-6. PubMed ID: 8933041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-invasive diagnosis of chronic beryllium disease in workers exposed to hazardous dust in Israel.
    Fireman E; Mazor O; Kramer M; Priel I; Lerman Y
    Occup Environ Med; 2010 Sep; 67(9):631-5. PubMed ID: 19955573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review: Progression of beryllium sensitization to chronic beryllium disease.
    Seidler A; Euler U; Müller-Quernheim J; Gaede KI; Latza U; Groneberg D; Letzel S
    Occup Med (Lond); 2012 Oct; 62(7):506-13. PubMed ID: 22705916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An official American Thoracic Society statement: diagnosis and management of beryllium sensitivity and chronic beryllium disease.
    Balmes JR; Abraham JL; Dweik RA; Fireman E; Fontenot AP; Maier LA; Muller-Quernheim J; Ostiguy G; Pepper LD; Saltini C; Schuler CR; Takaro TK; Wambach PF;
    Am J Respir Crit Care Med; 2014 Nov; 190(10):e34-59. PubMed ID: 25398119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic beryllium disease among dental technicians in Israel.
    Fireman E; Kramer MR; Priel I; Lerman Y
    Sarcoidosis Vasc Diffuse Lung Dis; 2006 Oct; 23(3):215-21. PubMed ID: 18038921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beryllium disease among construction trade workers at Department of Energy nuclear sites: A follow-up.
    Cloeren M; Dement J; Gaitens J; Hines S; Diaz L; Tembunde Y; Cranford K; Shorter J; Mosier T; Ringen K;
    Am J Ind Med; 2022 Sep; 65(9):708-720. PubMed ID: 35833586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for beryllium disease among construction trade workers at Department of Energy nuclear sites.
    Welch L; Ringen K; Bingham E; Dement J; Takaro T; McGowan W; Chen A; Quinn P
    Am J Ind Med; 2004 Sep; 46(3):207-18. PubMed ID: 15307119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metal-induced diffuse lung disease.
    Fontenot AP; Amicosante M
    Semin Respir Crit Care Med; 2008 Dec; 29(6):662-9. PubMed ID: 19221964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of lymphocyte proliferation tests in assessing occupational sensitization and disease.
    Hines SE; Pacheco K; Maier LA
    Curr Opin Allergy Clin Immunol; 2012 Apr; 12(2):102-10. PubMed ID: 22306552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in identifying beryllium sensitization and disease.
    Middleton D; Kowalski P
    Int J Environ Res Public Health; 2010 Jan; 7(1):115-24. PubMed ID: 20195436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rocky Flats Beryllium Health Surveillance.
    Stange AW; Furman FJ; Hilmas DE
    Environ Health Perspect; 1996 Oct; 104 Suppl 5(Suppl 5):981-6. PubMed ID: 8933045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic beryllium disease: uncommon disease, less common diagnosis.
    Middleton DC
    Environ Health Perspect; 1998 Dec; 106(12):765-7. PubMed ID: 9831535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The beryllium lymphocyte proliferation test: Relevant issues in beryllium health surveillance.
    Stange AW; Furman FJ; Hilmas DE
    Am J Ind Med; 2004 Nov; 46(5):453-62. PubMed ID: 15490468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interpreting borderline BeLPT results.
    Middleton DC; Mayer AS; Lewin MD; Mroz MM; Maier LA
    Am J Ind Med; 2011 Mar; 54(3):205-9. PubMed ID: 20957676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beryllium-stimulated neopterin as a diagnostic adjunct in chronic beryllium disease.
    Maier LA; Kittle LA; Mroz MM; Newman LS
    Am J Ind Med; 2003 Jun; 43(6):592-601. PubMed ID: 12768609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Process-related risk of beryllium sensitization and disease in a copper-beryllium alloy facility.
    Schuler CR; Kent MS; Deubner DC; Berakis MT; McCawley M; Henneberger PK; Rossman MD; Kreiss K
    Am J Ind Med; 2005 Mar; 47(3):195-205. PubMed ID: 15712254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.